跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,676 条关于
“Alto Neurosciences”
全部
1,676
临床试验
1,211
药物
150
机构
60
资讯
255
去年
New Wave of Depression Meds Target Novel Mechanisms Beyond Serotonin
去年
Alto Neuroscience's ALTO-300 Shows Promise in Phase 2b Trial for Major Depressive Disorder
去年
Alto Neuroscience Faces Class Action Lawsuit Following ALTO-100 Phase 2b Trial Failure
8个月前
Alto Neuroscience Secures Key Patent for ALTO-207 Depression Treatment, Extending IP Protection to Mid-2040s
11个月前
Alto Neuroscience Receives FDA Fast Track Designation for ALTO-101 Schizophrenia Cognitive Impairment Treatment
上个月
Alto Neuroscience Expands ALTO-207 Phase 3 Program in Treatment-Resistant Depression, Backed by $100 Million Financing
去年
Alto Neuroscience's ALTO-100 Fails to Meet Primary Endpoint in Phase 2b Depression Trial
去年
Alto Neuroscience's ALTO-100 Fails Phase 2b Trial for Major Depressive Disorder
去年
Alto's ALTO-300 Shows Promise in Phase 2b Trial for Treatment-Resistant Depression
去年
Klotho Neurosciences Advances Gene Therapy Manufacturing for ALS Treatment
第 1 页,共 26 页
上一页
下一页